Sensei biotherapeutics to participate in the berenberg virtual u.s. ceo conference on tuesday, november 9, 2021

Boston, nov. 03, 2021 (globe newswire) -- sensei biotherapeutics, inc. (nasdaq: snse), an immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, today announced that john celebi, president and chief executive officer, will participate in a fireside chat at the berenberg virtual u.s. ceo conference on tuesday, november 9 at 10:00 a.m. est.
SNSE Ratings Summary
SNSE Quant Ranking